Vevo Therapeutics
Vevo Therapeutics
vevo.ai

Locations

North America · San Francisco, CA, USA

industry

Biotechnology · Data and Analytics · DeepTech · Health · Software

Size

11-50 employees

Stage

Seed

founded in

2022

Vevo Therapeutics is a biotechnology company utilizing its Mosaic in vivo drug discovery platform and advanced AI models to develop better drugs for a broader patient population. The Mosaic platform is the first to enable scalable in vivo data generation with single-cell precision, allowing for a comprehensive understanding of drug interactions within diverse patient cells. By leveraging high-resolution in vivo data, Vevo aims to create the world's largest atlas of drug responses, addressing the limitations of traditional in vitro models and enhancing the drug discovery process. Founded by experts in life sciences and technology, Vevo is positioned to reshape drug discovery and improve patient outcomes.

Something looks off?
Open jobs at Vevo Therapeutics

On-site & Remote